Objective: To evaluate the benefits and harms of oral centrally acting antiobesity medicinal products in pivotal trials.
Methods: The European Medicines Agency and Federal Drug Administration websites, PubMed, and ClinicalTrials.gov were searched to identify pivotal trials used to gain marketing authorizations.